Tuesday 29 September

Location:  Room S3
08:30 - 08:40 | Welcome and Introduction – IATP Education Committee
08:40 - 09:30 | Safety Paradox of GLP-1 Drugs: Reconciling Preclinical Signals with Clinical Cardiovascular Benefits – John L. Vahle
09:30 - 10:10 | Emerging Challenges and Safety Considerations in T-cell Engager and CAR-T in Oncology Therapeutics – Anna-Lena Frisk
10:10 - 10:40 | Coffee Break
10:40 - 11:20 | Adversity Calls in Oncology Nonclinical Development: Are we asking the Right Questions? – Franck Chanut
11:20 - 12:00 | CRO Perspectives on Current Trends and Challenges in Nonclinical Safety Assessment – Sarah Gould & Annette Romeike
12:00 - 12:30 | Panel Discussion
12:30 - 12:35 | Closing Remarks – IATP Education Committee
12:30 - 13:30 | Lunch Break | Room S4 - Exhibition

Location: Room S3
Topic 1: Cutting Edge of ToxPath
13:30 - 13:45 | Welcome by ESTP Chair - Vanessa Schumacher
13:45 - 14:45 | Highly multiplexed imaging in the omics era: understanding tissue structures in health and disease - Bernd Bodenmiller
14:45 - 15:15 | Tissue based Mass Spectrometry beyond morphology - there is more to see behind nice pictures - Bogdan Munteanu
15:15 - 15:45 | Spatial transcriptomics/proteomics in toxicologic pathology - Kerstin Hahn

15:45 - 16:15 | Afternoon Coffee Break | Room S4 - Exhibition

16:15 - 16:30 | TBC
16:30 - 17:00 | Spatial transcriptomics of Crohn's disease: Advancing Pathobiology and Target Discovery in Biopharma - Sunish Mohanan
17:00 - 17:45 | Acceleration of drug discovery through multi-omics imaging data analysis (title to be confirmed) - Richard Goodwin